<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2titles.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemtitles.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel>
    <title>Latest Headlines from Cafepharma</title>
    <link>http://www.cafepharma.com</link>
    <description>Here are the latest pharma news headlines from cafepharma's home page. Read and comment on the latest pharma news at http://www.cafepharma.com.</description>
    <lastBuildDate>Tue, 10 Nov 2009 06:48:30 GMT</lastBuildDate>
    <generator>Feed43 Proxy/1.0 (www.feed43.com)</generator>
    <ttl>60</ttl>

<image><link>http://www.cafepharma.com</link><url>http://www.cafepharma.com/a_cafepharma_newsfeed.png</url><title>a cafepharma newsfeed</title></image><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/Cafepharma" type="application/rss+xml" /><feedburner:emailServiceId>Cafepharma</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><feedburner:feedFlare href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.feedburner.com%2FCafepharma" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare href="http://www.newsgator.com/ngs/subscriber/subext.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FCafepharma" src="http://www.newsgator.com/images/ngsub1.gif">Subscribe with NewsGator</feedburner:feedFlare><feedburner:feedFlare href="http://feeds.my.aol.com/add.jsp?url=http%3A%2F%2Ffeeds.feedburner.com%2FCafepharma" src="http://o.aolcdn.com/favorites.my.aol.com/webmaster/ffclient/webroot/locale/en-US/images/myAOLButtonSmall.gif">Subscribe with My AOL</feedburner:feedFlare><feedburner:feedFlare href="http://www.bloglines.com/sub/http://feeds.feedburner.com/Cafepharma" src="http://www.bloglines.com/images/sub_modern11.gif">Subscribe with Bloglines</feedburner:feedFlare><feedburner:feedFlare href="http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.feedburner.com%2FCafepharma" src="http://www.netvibes.com/img/add2netvibes.gif">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2FCafepharma" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare href="http://www.pageflakes.com/subscribe.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FCafepharma" src="http://www.pageflakes.com/ImageFile.ashx?instanceId=Static_4&amp;fileName=ATP_blu_91x17.gif">Subscribe with Pageflakes</feedburner:feedFlare><feedburner:browserFriendly>For more pharma news, please visit our homepage at http://www.cafepharma.com</feedburner:browserFriendly><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item>
<guid isPermaLink="false">826dab8afb23df0f4db7b2c842019ca5</guid>
<title>Guidant: The Gift That Keeps on Giving</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/wb5RVT9RQs4/guidant-the-gift-that-keeps-on-giving.aspx</link>
<description>&lt;font color="#990000"&gt;Motley Fool&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=wb5RVT9RQs4:9cBxrQoRDFU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/wb5RVT9RQs4" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.fool.com/investing/general/2009/11/09/guidant-the-gift-that-keeps-on-giving.aspx</feedburner:origLink></item>
<item>
<guid isPermaLink="false">ed4f99ee373101c79b221e734e1e0b89</guid>
<title>J&amp;J Axes Evolence, Its "Too Lumpy" Dermal Filler; Allergan, Medicis Rejoice</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/CQJ8hUUm3lI/</link>
<description>&lt;font color="#990000"&gt;BNET Pharma&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=CQJ8hUUm3lI:hKNzd0idRYg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/CQJ8hUUm3lI" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://industry.bnet.com/pharma/10005205/j-allergan-medicis-rejoice/?tag=shell;content</feedburner:origLink></item>
<item>
<guid isPermaLink="false">99eea78e64d4df22608923ece25d1afb</guid>
<title>Three Core Biotech Holdings: Isis, Ligand and Vical</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/aU449xNLcE4/172287-three-core-biotech-holdings-isis-ligand-and-vical</link>
<description>&lt;font color="#990000"&gt;Seeking Alpha&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=aU449xNLcE4:qDu9CEtqsO4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/aU449xNLcE4" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://seekingalpha.com/article/172287-three-core-biotech-holdings-isis-ligand-and-vical?source=yahoo</feedburner:origLink></item>
<item>
<guid isPermaLink="false">4a85b98c0d47b6a61a62aeab52cf592b</guid>
<title>Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/L-K2jqzKeQE/200911060829DOWJONESDJONLINE000445_FORTUNE5.htm</link>
<description>&lt;font color="#990000"&gt;CNN Money&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=L-K2jqzKeQE:GrmnWcnRtbQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/L-K2jqzKeQE" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://money.cnn.com/news/newsfeeds/articles/djf500/200911060829DOWJONESDJONLINE000445_FORTUNE5.htm</feedburner:origLink></item>
<item>
<guid isPermaLink="false">ddbdb0c80a2c00c20e7e6b54077613ef</guid>
<title>Cypress Bioscience says 3rd-quarter loss grew due to costs connected to launch of Savella</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/4XWBgfsbKMo/Cypress-Bioscience-takes-apf-744343088.html</link>
<description>&lt;font color="#990000"&gt;Yahoo/AP&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=4XWBgfsbKMo:GJHGSGZqPQM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/4XWBgfsbKMo" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://finance.yahoo.com/news/Cypress-Bioscience-takes-apf-744343088.html?x=0&amp;.v=1</feedburner:origLink></item>
<item>
<guid isPermaLink="false">6e38acd87df8b8daeaef2215829b8b47</guid>
<title>Pfizer to shutter six out of 20 R&amp;D sites</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/UehjRbAnGmw/pfizer-to-shutter-six-out-of-20-rd-sites-2009-11-09</link>
<description>&lt;font color="#990000"&gt;Marketwatch&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=UehjRbAnGmw:8MwNZunxQVA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/UehjRbAnGmw" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.marketwatch.com/story/pfizer-to-shutter-six-out-of-20-rd-sites-2009-11-09?siteid=yhoof2</feedburner:origLink></item>
<item>
<guid isPermaLink="false">d4dcc0f624470fe0c169aa775d0101e7</guid>
<title>Ranbaxy: FDA Issues Will Take Long Time To Resolve</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/cQhjFF4IfFw/BT-CO-20091109-704907.html</link>
<description>&lt;font color="#990000"&gt;WSJ Online&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=cQhjFF4IfFw:bC17r8AoGdM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/cQhjFF4IfFw" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://online.wsj.com/article/BT-CO-20091109-704907.html</feedburner:origLink></item>
<item>
<guid isPermaLink="false">05a22cf94d1e74e30108749bffca8700</guid>
<title>Enzon sells specialty drug business for $300M</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/t-ASuh9qnz0/Enzon-sells-specialty-drug-apf-3781777258.html</link>
<description>&lt;font color="#990000"&gt;Yahoo/AP&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=t-ASuh9qnz0:ofZHgjP33m4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/t-ASuh9qnz0" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://finance.yahoo.com/news/Enzon-sells-specialty-drug-apf-3781777258.html?x=0&amp;.v=2</feedburner:origLink></item>
<item>
<guid isPermaLink="false">4542e4aa99ed2813d6556ef3dab5ce7c</guid>
<title>Insurers, Drugmakers Turn to Senate for Health-Bill Changes</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/i7yjJJTbfJo/news</link>
<description>&lt;font color="#990000"&gt;Bloomberg&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=i7yjJJTbfJo:37oAcTPov94:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/i7yjJJTbfJo" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bloomberg.com/apps/news?pid=20601087&amp;sid=auD2TZKx.l2c&amp;pos=8</feedburner:origLink></item>
<item>
<guid isPermaLink="false">944a48d41ffd56c95c0a5181a22a8947</guid>
<title>200 pharma whistleblowers in line for court</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/WtjAb4SBX1M/2009-11-06</link>
<description>&lt;font color="#990000"&gt;Fierce Pharma&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=WtjAb4SBX1M:wpjP-ycCxHM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/WtjAb4SBX1M" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.fiercepharma.com/story/200-pharma-whistleblowers-line-court/2009-11-06</feedburner:origLink></item>
<item>
<guid isPermaLink="false">13b4a354810986bb57b52d6d62b8201e</guid>
<title>Xoma Waffles on Timing of Drug Partnership</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/GektHYJ4wyI/xoma-waffles-on-timing-of-drug-partnership-biobuzz.html</link>
<description>&lt;font color="#990000"&gt;TheStreet.com&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=GektHYJ4wyI:FO7UYrEJq0c:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/GektHYJ4wyI" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.thestreet.com/_yahoo/story/10623920/1/xoma-waffles-on-timing-of-drug-partnership-biobuzz.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</feedburner:origLink></item>
<item>
<guid isPermaLink="false">0ca37cb3cc81ce6e444891cfc062a255</guid>
<title>Pfizer Aiming for 30,900 Layoffs Through 2012</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/YAsC4a79Y_8/</link>
<description>&lt;font color="#990000"&gt;BNET Pharma&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=YAsC4a79Y_8:UHFXjVE0PBk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/YAsC4a79Y_8" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://industry.bnet.com/pharma/10005173/pfizer-aiming-for-30900-layoffs-through-2012/?tag=shell;content</feedburner:origLink></item>
<item>
<guid isPermaLink="false">da9f5186cc44d0169a00e2b9b3b25062</guid>
<title>Despite Omeros Flop, Trius and Other Biotech IPO Hopefuls Might Fare Better</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/NMpzURYUTsQ/</link>
<description>&lt;font color="#990000"&gt;BNET Pharma&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=NMpzURYUTsQ:gU1eJXt5nkk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/NMpzURYUTsQ" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://industry.bnet.com/pharma/10005194/despite-omeros-flop-trius-and-other-biotech-ipo-hopefuls-might-fare-better/</feedburner:origLink></item>
<item>
<guid isPermaLink="false">7845b6b63acd7a685ea1f09a7c9d5eca</guid>
<title>Forest Laboratories: Steady Growth in Sales and Earnings</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/8d0Qjys_r0I/172192-forest-laboratories-steady-growth-in-sales-and-earnings</link>
<description>&lt;font color="#990000"&gt;Seeking Alpha&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=8d0Qjys_r0I:JV_dQROuFOs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/8d0Qjys_r0I" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://seekingalpha.com/article/172192-forest-laboratories-steady-growth-in-sales-and-earnings?source=yahoo</feedburner:origLink></item>
<item>
<guid isPermaLink="false">7aac9b80270c5608b374f76c8c401c44</guid>
<title>Cephalon's Upside and Downside</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/ispUPKgMPT8/172053-cephalon-s-upside-and-downside</link>
<description>&lt;font color="#990000"&gt;Seeking Alpha&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=ispUPKgMPT8:fIp6-fomMaM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/ispUPKgMPT8" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://seekingalpha.com/article/172053-cephalon-s-upside-and-downside?source=yahoo</feedburner:origLink></item>
<item>
<guid isPermaLink="false">25a8e8a0a3dd18d4aa5de2cbab87d9c8</guid>
<title>XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/0B8mDGXLgXY/FDA-extends-review-of-apf-554657836.html</link>
<description>&lt;font color="#990000"&gt;Yahoo/AP&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=0B8mDGXLgXY:ZOshZGFumAI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/0B8mDGXLgXY" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://finance.yahoo.com/news/FDA-extends-review-of-apf-554657836.html?x=0&amp;.v=2</feedburner:origLink></item>
<item>
<guid isPermaLink="false">71b75b3b8025f5150ea1883a20149d68</guid>
<title>D.C. Vaccine Conference: Why Investors Should Stay Tuned</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/nenGKH-BMMo/172127-d-c-vaccine-conference-why-investors-should-stay-tuned</link>
<description>&lt;font color="#990000"&gt;Seeking Alpha&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=nenGKH-BMMo:d_wBXVnf5io:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/nenGKH-BMMo" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://seekingalpha.com/article/172127-d-c-vaccine-conference-why-investors-should-stay-tuned?source=yahoo</feedburner:origLink></item>
<item>
<guid isPermaLink="false">1f4d53d4918e4500736cf50ad5c499b3</guid>
<title>Elan, Biogen change Tysabri label due to PML risk</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/GZxwow5lqAI/idCNL718499120091107</link>
<description>&lt;font color="#990000"&gt;Reuters&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=GZxwow5lqAI:uqPBENQZ3VI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/GZxwow5lqAI" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.reuters.com/article/marketsNews/idCNL718499120091107?rpc=44</feedburner:origLink></item>
<item>
<guid isPermaLink="false">ebd041a5fedb3b6c013698a60aa5b8a5</guid>
<title>Pfizer Broke the Law by Promoting Drugs for Unapproved Uses</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/95_efyQYo5M/news</link>
<description>&lt;font color="#990000"&gt;Bloomberg&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=95_efyQYo5M:P6DUve-tqxc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/95_efyQYo5M" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bloomberg.com/apps/news?pid=20601202&amp;sid=a4yV1nYxCGoA</feedburner:origLink></item>
<item>
<guid isPermaLink="false">e5170fd4278fc29ceaf2369759a3566a</guid>
<title>House, Senate Health-Care Legislation: Side-by-Side Comparison</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/rqLUeSnrbqg/news</link>
<description>&lt;font color="#990000"&gt;Bloomberg&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=rqLUeSnrbqg:87hOFQ8w4S0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/rqLUeSnrbqg" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bloomberg.com/apps/news?pid=20601202&amp;sid=alc.ViCBRg9g</feedburner:origLink></item>
<item>
<guid isPermaLink="false">1c319659deb807987641b8ce8b3c550c</guid>
<title>Alcon Boosts Presence In Eye Disease Market</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/zutfwYtJu18/Alcon-Boosts-Presence-In-Eye-ibd-2936218377.html</link>
<description>&lt;font color="#990000"&gt;Yahoo/Investors Business Daily&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=zutfwYtJu18:GLjX8Jr6Pg0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/zutfwYtJu18" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://finance.yahoo.com/news/Alcon-Boosts-Presence-In-Eye-ibd-2936218377.html?x=0&amp;.v=1</feedburner:origLink></item>
<item>
<guid isPermaLink="false">d1a9cd2769275c4ed65cced250812fcc</guid>
<title>Boston Scientific Sets $296 Million Settlement on Devices</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/8Svef3hIfD8/</link>
<description>&lt;font color="#990000"&gt;WSJ Online&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=8Svef3hIfD8:fbsfP3UCJxA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/8Svef3hIfD8" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://blogs.wsj.com/health/2009/11/06/boston-scientific-sets-296-million-settlement-on-devices/?mod=yahoo_hs</feedburner:origLink></item>
<item>
<guid isPermaLink="false">b5a950f912da81587e68aa76173a8611</guid>
<title>No Product Revenues, Plenty of Risk: Buy Exelixis?</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/yjqRR5NsOR0/14081545</link>
<description>&lt;font color="#990000"&gt;CNBC&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=yjqRR5NsOR0:XSNEWSTN9uw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/yjqRR5NsOR0" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.cnbc.com/id/33728731/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&amp;par=yahoo</feedburner:origLink></item>
<item>
<guid isPermaLink="false">19be3ee29ef1519a796524ca3faa6952</guid>
<title>China Is Growth Market for Novartis</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/Y_MLHE6H0Cs/172103-china-is-growth-market-for-novartis</link>
<description>&lt;font color="#990000"&gt;Seeking Alpha&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=Y_MLHE6H0Cs:NKAG_jYYFqw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/Y_MLHE6H0Cs" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://seekingalpha.com/article/172103-china-is-growth-market-for-novartis</feedburner:origLink></item>
<item>
<guid isPermaLink="false">f1beecd2f33fc1c5508fa49db14292fb</guid>
<title>Chinese co to fund D-Pharm Phase III trial</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/oji6JVQ4euE/DocView.asp</link>
<description>&lt;font color="#990000"&gt;Globes, Israel&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=oji6JVQ4euE:stK8ZpCA2Js:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/oji6JVQ4euE" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.globes.co.il/serveen/globes/DocView.asp?did=1000512036&amp;fid=1725</feedburner:origLink></item>
<item>
<guid isPermaLink="false">451c4656a8231078ace77f3c496b5b13</guid>
<title>Small Cap Biotechs and Government Policy Makers Meet in D.C.(OTC:ADXS),(AMEX:CVM),(CVE:IMV)</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/IAYZsZeFVKA/</link>
<description>&lt;font color="#990000"&gt;Smallcap Network&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=IAYZsZeFVKA:a6vQGCU4RM8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/IAYZsZeFVKA" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://community.smallcapnetwork.com/Small-Cap-Biotechs-and-Government-Policy-Makers-Meet-in-D-C-OTC-ADXS-AMEX-CVM-CVE-IMV/s/via/367/article/view/p/mid/1/id/15/</feedburner:origLink></item>
<item>
<guid isPermaLink="false">6e5afab891b72f354d32935a13974255</guid>
<title>Dr. Reddyâs Laboratories (RDY): Best Pharma Stock In India</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/ypw7x4T9mjI/</link>
<description>&lt;font color="#990000"&gt;The Wall St Transcript&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=ypw7x4T9mjI:2DIYY2ux1h8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/ypw7x4T9mjI" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.twst.com/blog/2009/11/08/citi-investment-research-dr-reddys-laboratories-rdy-best-pharma-stock-pick-in-india/</feedburner:origLink></item>
<item>
<guid isPermaLink="false">5952de36e3a39e874877f7b03c0c4809</guid>
<title>Why We Need A Healthy Biotech Industry</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/yOWLxLyKBRw/news44930.html</link>
<description>&lt;font color="#990000"&gt;Worcester Business Journal&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=yOWLxLyKBRw:nzFo233Yh60:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/yOWLxLyKBRw" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.wbjournal.com/news44930.html</feedburner:origLink></item>
<item>
<guid isPermaLink="false">965b4f8438ffbb0ac3d3c1827be0f6d2</guid>
<title>Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (AB...</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/3Ubcqs64qeg/</link>
<description>&lt;font color="#990000"&gt;prnewschannel.com&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=3Ubcqs64qeg:-ZHoRxfaLs4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/3Ubcqs64qeg" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.prnewschannel.com/absolutenm/templates/?z=4&amp;a=1823</feedburner:origLink></item>
<item>
<guid isPermaLink="false">4ec688155714396104db0e0159becbbc</guid>
<title>Biotech Blooms at Eli Lilly</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/_JTOi8DQnPs/172104-biotech-blooms-at-eli-lilly</link>
<description>&lt;font color="#990000"&gt;Seeking Alpha&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=_JTOi8DQnPs:b5lwHRO5JDE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/_JTOi8DQnPs" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://seekingalpha.com/article/172104-biotech-blooms-at-eli-lilly?source=yahoo</feedburner:origLink></item>
<item>
<guid isPermaLink="false">247fc8fec75b26917da918af67b348f9</guid>
<title>Santarus Inc. Q3 2009 Earnings Call Transcript</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/UEv3KTaet4Y/171355-santarus-inc-q3-2009-earnings-call-transcript</link>
<description>&lt;font color="#990000"&gt;Seeking Alpha&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=UEv3KTaet4Y:JmcdDdqsd68:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/UEv3KTaet4Y" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://seekingalpha.com/article/171355-santarus-inc-q3-2009-earnings-call-transcript</feedburner:origLink></item>
<item>
<guid isPermaLink="false">d8873852ce61bc6e52484353e8d25f13</guid>
<title>Living Without Blockbusters</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/4dzRVXMLWIM/outfront-sanofi-aventis-pharm-living-without-blockbusters.html</link>
<description>&lt;font color="#990000"&gt;Forbes&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=4dzRVXMLWIM:X8CFaOBtutc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/4dzRVXMLWIM" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.forbes.com/global/2009/1116/outfront-sanofi-aventis-pharm-living-without-blockbusters.html?partner=yahoomag</feedburner:origLink></item>
<item>
<guid isPermaLink="false">1b4c113330b71503b944be5981a7f43c</guid>
<title>Money-Making Mood Stabilizers</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/0INKcecjSVo/14081545</link>
<description>&lt;font color="#990000"&gt;CNBC&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=0INKcecjSVo:lnsmUybTYkA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/0INKcecjSVo" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.cnbc.com/id/33728742/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&amp;par=yahoo</feedburner:origLink></item>
<item>
<guid isPermaLink="false">d1fe1d629356eb2f3bd04341894aa6ba</guid>
<title>Halozyme Study Results Demonstrate Significantly Less Absorption Variability for Insulin Lispro Administered with PH20 E...</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/Zk_e3YzNTho/</link>
<description>&lt;font color="#990000"&gt;BusinessWire&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=Zk_e3YzNTho:FXgIeqcQOjU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/Zk_e3YzNTho" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&amp;newsId=20091106005957&amp;newsLang=en</feedburner:origLink></item>
<item>
<guid isPermaLink="false">5174f7d50ebda67ac87479307255e663</guid>
<title>Cramerâs 8 Picks for Cancer's Cure</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/TRFbkEdH8kU/14081545</link>
<description>&lt;font color="#990000"&gt;CNBC&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=TRFbkEdH8kU:LjEz8CxdKVo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/TRFbkEdH8kU" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.cnbc.com/id/33728388/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&amp;par=yahoo</feedburner:origLink></item>
<item>
<guid isPermaLink="false">5e01864be0cce994d078e9814241ad01</guid>
<title>Genmab to cut 130 jobs in Brooklyn Park, sell biotech factory</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/WgUb9tiU81M/daily62.html</link>
<description>&lt;font color="#990000"&gt;bizjournals.com&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=WgUb9tiU81M:Th6CrHFe6GM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/WgUb9tiU81M" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://twincities.bizjournals.com/twincities/stories/2009/11/02/daily62.html?ana=yfcpc</feedburner:origLink></item>
<item>
<guid isPermaLink="false">8dc6bdbec0ba435174c68fd054854f87</guid>
<title>DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations</title>
<link>http://feedproxy.google.com/~r/Cafepharma/~3/X4dfh9qXIzw/</link>
<description>&lt;font color="#990000"&gt;BusinessWire&lt;/font&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Cafepharma?a=X4dfh9qXIzw:n3jQKsgCNis:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Cafepharma?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Cafepharma/~4/X4dfh9qXIzw" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&amp;newsId=20091107005004&amp;newsLang=en</feedburner:origLink></item>


  </channel>
</rss>
